Of patients who undergo abdominal surgery, over 50% develop adverse adhesions between organs. Adhesions often lead to pain, infertility and, in severe cases, to life-threatening bowel obstruction. A new drug developed by the startup company Akesion removes the main precursor of these adhesions preventing the formation of adhesions as well as risky repeat surgeries that are stressful to patients.
Thank you for helping us with your report! Please state the error you found within the video and we'll check out what's bugging you.